CAR-T Therapy

0. China's medical services offer top-notch treatment capabilities, while Trisana Medguide provides reliable support for patient arrival. High-quality medical resources require professional service delivery. Choosing to seek medical treatment in China allows you to rely on our top-tier specialized resources, professional medical team, rigorous service processes, fully managed one-stop service, and long-term safety net. This ensures that every patient experiences: less waiting time, fewer detours, precise medical care, worry-free treatment, and efficient recovery, maximizing the technological, time-saving, and cost-effective advantages of cross-border medical care in China.

1. Connect with China's top medical resources to accurately and personalizedly match hospitals and specialists.

We connect you directly with China's top 10 tertiary hospitals and academician-level experts, providing you with accurate expert appointments, surgery schedule bookings, and personalized treatment plans, eliminating detours in your medical journey.

2. Rigorous and traceable service processes ensure precise and efficient medical tourism.

From initial consultation and assessment, visa assistance, and itinerary planning, to in-hospital medical coordination, postoperative rehabilitation management, and long-tail services after returning home, every step is managed with standard operating procedures (SOPs).

3. Assemble an elite service team to provide butler-style, one-on-one care throughout the entire process.

Our team comprises six elite professionals with advanced degrees, including medical masters and doctors, specializing in medical consultation, medical translation, visa assistance, health management, information development, and professional care. We offer customized service plans and provide one-on-one concierge-style care throughout the entire process.

4. Integrated medical tourism one-stop fully managed VIP service

We offer full-service concierge services, including private car service, hotel and apartment booking, medical services such as medical escort and translation, and access to expedited medical care, as well as daily care such as housekeeping and customized meals, making patients and their families feel at home and worry-free throughout the entire process.

1. Technology is in sync with international standards, ranking among the world's top tier.

Multiple domestically produced CAR-T products have been approved, placing China among the world's leading countries in the number of approved CAR-T products. The technology is on par with Europe and the United States, demonstrating that the R&D capabilities of domestic pharmaceutical companies have reached world-class levels. Significant breakthroughs have been achieved in target development and production processes, and the efficacy and safety have gained international authoritative recognition.

2. A vast amount of clinical experience to handle complex cases.

With a world-leading number of registered clinical studies covering multiple subtypes of hematologic malignancies and exploring a wider range of indications, the hospital boasts a large patient base that provides physicians with extensive practical experience, giving them a significant advantage in managing relapsed or refractory cases, side effect management, and personalized treatment plans.

3. Significant cost advantages, improving treatment accessibility

Compared to the hundreds of thousands of dollars required for treatment in Europe and the United States, the cost of treatment in China is significantly lower, making cutting-edge therapies an affordable clinical option instead of exorbitantly priced drugs. Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.

4. Real-world benefits

It has successfully treated thousands of patients with an excellent objective remission rate, bringing long-term survival hope to patients with relapsed and refractory disease.

Drug approval reforms are accelerating the launch of innovative therapies, allowing patients to benefit from cutting-edge global cell therapy technologies as soon as possible.